Studies have shown that CCL20 derived from tumor cells interacts with CD19CD5 B cells overexpressed by CCR6 to promote the development of HCC, possibly through enhanced angiogenesis (He et al., 2017). Here, CCR6 is linked to hepatocellular carcinoma.